Provided by Tiger Fintech (Singapore) Pte. Ltd.

Regulus Therapeutics

1.48
+0.10007.25%
Post-market: 1.480.00000.00%17:13 EDT
Volume:245.39K
Turnover:367.02K
Market Cap:96.94M
PE:-1.60
High:1.56
Open:1.37
Low:1.35
Close:1.38
Loading ...

Regulus Therapeutics Inc - Phase 1B Trial Shows Continued Mechanistic Dose Response

THOMSON REUTERS
·
29 Jan

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates From Its Autosomal Dominant Polycystic Kidney Disease (Adpkd) Program for Farabursen (Rgls8429)

THOMSON REUTERS
·
29 Jan

Regulus Therapeutics Announces Positive Clinical and Regulatory Updates from its Autosomal Dominant Polycystic Kidney Disease (ADPKD) Program for Farabursen (RGLS8429)

PR Newswire
·
29 Jan

With 64% institutional ownership, Regulus Therapeutics Inc. (NASDAQ:RGLS) is a favorite amongst the big guns

Simply Wall St.
·
08 Dec 2024

Regulus Therapeutics Announces Participation at Upcoming Healthcare Investment Conferences

PR Newswire
·
26 Nov 2024

Regulus Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
11 Nov 2024

Buy Rating for Regulus Therapeutics Driven by Promising Clinical and Regulatory Prospects for RGLS8429

TIPRANKS
·
11 Nov 2024

Regulus Therapeutics Inc reports results for the quarter ended in September 30 - Earnings Summary

Reuters
·
08 Nov 2024

Regulus Therapeutics GAAP EPS of -$0.21 misses by $0.04

seekingalpha
·
08 Nov 2024

Regulus: Q3 Earnings Snapshot

Associated Press Finance
·
08 Nov 2024

Regulus Therapeutics Q3 EPS $(0.21) Misses $(0.17) Estimate

Benzinga
·
08 Nov 2024

Regulus Therapeutics Reports Third Quarter 2024 Financial Results and Recent Updates

PR Newswire
·
08 Nov 2024

Regulus Therapeutics Inc expected to post a loss of 17 cents a share - Earnings Preview

Reuters
·
06 Nov 2024

Regulus Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
30 Oct 2024

Positive Buy Rating for Regulus Therapeutics Driven by Promising Phase 1b Results and Strategic Patent Agreement

TIPRANKS
·
30 Oct 2024

These 2 ‘Strong Buy’ Penny Stocks Could Rally Over 500%, Say Analysts

TipRanks
·
29 Oct 2024